Who Owns Intuitive Surgical Company?

Intuitive Surgical Bundle

Get Full Bundle:

	BCG	$15	$10
	5 FORCES	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Intuitive Surgical?

Understanding Intuitive Surgical's ownership is key to its strategic direction in robotic surgery. Its 2000 IPO marked a significant shift from private to public control, shaping its accountability and influence.

Founded in 1995, the company pioneered robotic-assisted surgery with its da Vinci system. Today, it's a global leader, with over 10,600 da Vinci systems installed worldwide by the end of 2024.

Who owns Intuitive Surgical?

Intuitive Surgical was established in November 1995 by a trio of visionary individuals: Dr. Frederic Moll, John Gordon Freund, and Robert G. Younge. Dr. Moll, a recognized pioneer in medical robotics, was drawn to a robotic surgical system developed at SRI International in 1994. When his employer at the time did not pursue the project, Moll was connected with John Freund, who had recently left Acuson Corporation.

Founding Visionaries

The company's inception in 1995 was driven by the collaboration of Dr. Frederic Moll, John Freund, and Robert Younge. Their combined expertise was crucial in developing the initial business plan and securing early funding.

Intellectual Property Acquisition

John Freund played a key role by negotiating an option to acquire the intellectual property from SRI International. This acquisition formed the technological backbone of the future company.

Initial Funding and Investment

Securing venture capital was a critical early step. Firms like the Mayfield Fund, Sierra Ventures, and Morgan Stanley were among the early investors who acquired stakes during this foundational period.

Early Company Name

The company was initially incorporated under the name Intuitive Surgical Devices, Inc. This early designation reflected the focus on developing advanced surgical technologies.

Development of the da Vinci System

The foundational work involved refining the SRI system into a prototype. This prototype eventually evolved into the groundbreaking da Vinci Surgical System, revolutionizing minimally invasive surgery.

Founder Contributions

While specific initial equity details are not public, the founders' collective efforts in securing intellectual property and initial funding were paramount. Their strategic direction shaped the company's early ownership structure.

The early ownership of Intuitive Surgical was characterized by the foundational contributions of its founders and the strategic investment from venture capital firms. Dr. Frederic Moll, John Gordon Freund, and Robert G. Younge collaborated to secure the necessary intellectual property and funding to launch the company. Early investors, including the Mayfield Fund, Sierra Ventures, and Morgan Stanley, acquired stakes, laying the groundwork for the company's future growth and public trading. The collective efforts of these individuals and firms were instrumental in the development and eventual commercialization of the da Vinci Surgical System, a testament to their shared vision and the company's innovative approach to surgical robotics. Understanding the Revenue Streams & Business Model of Intuitive Surgical provides further context on how this early ownership structure supported the company's trajectory.

Intuitive Surgical SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Intuitive Surgical's journey from a privately held venture to a publicly traded entity began with its Initial Public Offering (IPO) in 2000, a move that raised $46 million and opened its doors to public investment. This transition marked a significant shift in its ownership landscape, paving the way for its current substantial market presence.

The ownership structure of Intuitive Surgical is predominantly characterized by a strong presence of institutional investors, who collectively manage a significant majority of the company's shares. As of February 25, 2025, these entities held approximately 87% of the company's stock, underscoring their considerable influence on its market performance and strategic direction. This widespread institutional backing is further detailed by the 3,488 institutional owners and shareholders who have filed the necessary forms with the SEC, collectively holding 354,465,241 shares. Among the top institutional shareholders as of March 31, 2025, are Vanguard Group Inc., holding 32,665,531 shares, and BlackRock, Inc., with 31,449,561 shares, followed by State Street Corp holding 15,369,332 shares. The influence of mutual funds, a segment within institutional investors, also grew, reaching 93.26% of holdings in May 2025. While the direct shareholdings of the company's founders are not as prominently detailed in current reports, their foundational vision and ongoing leadership have been instrumental in the company's substantial growth. Gary S. Guthart, who transitioned to executive chair of the board in July 2025 after serving as CEO since 2010, and Dave Rosa, who assumed the CEO role on July 1, 2025, represent long-term leadership deeply intertwined with the company's strategic development. The company's financial health, demonstrated by a total equity increase to $16.5 billion in 2024 and shareholder equity reaching $17.208 billion for the quarter ending March 31, 2025—a 22.51% year-over-year increase—reflects the positive impact of its ownership structure and continuous investment in innovation.

Intuitive Surgical's Shareholder Landscape

Institutional investors are the primary owners of Intuitive Surgical, holding a vast majority of its shares.

• Institutional investors hold approximately 87% of Intuitive Surgical shares as of February 25, 2025.
• Vanguard Group Inc. and BlackRock, Inc. are among the largest institutional shareholders.
• The company's market capitalization reached approximately $173 billion as of July 28, 2025.
• Shareholder equity saw a significant increase of 22.51% year-over-year by March 31, 2025.
• Long-term leadership, including Gary S. Guthart and Dave Rosa, continues to shape the company's strategy.

Intuitive Surgical PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Board of Directors at Intuitive Surgical is structured to ensure robust oversight and strategic direction, featuring both internal leadership and independent experts. As of July 1, 2025, Gary S. Guthart, PhD, serves as Executive Chair of the Board, with David J. Rosa as Chief Executive Officer and a board member. Craig H. Barratt, PhD, holds the position of Lead Independent Director, guiding the board’s independent functions.

Intuitive Surgical adheres to a straightforward voting structure where each share of common stock carries one vote, with no provisions for cumulative voting. This ensures that voting power is directly proportional to share ownership, and there are no special classes of stock that grant disproportionate control to any specific group. As of February 29, 2024, the company had 354,448,735 shares of common stock outstanding, a figure that grew to 358 million total shares outstanding by March 31, 2025. The company has not experienced recent proxy contests or significant activist campaigns that have altered its governance or strategic direction. The substantial influence on company decisions rests with its institutional investors, who held approximately 87% of the shares as of February 2025, underscoring their significant role in Intuitive Surgical ownership and strategic outcomes.

Understanding Shareholder Influence

Institutional investors wield considerable power in shaping the direction of Intuitive Surgical due to their large shareholdings. This concentration of ownership means their investment decisions and voting patterns are critical factors in the company's governance.

• Institutional investors owned about 87% of shares as of February 2025.
• The company uses a one-share-one-vote system, simplifying voting power distribution.
• There are no dual-class shares, ensuring equal voting rights per share.
• This structure emphasizes the collective influence of major shareholders on company strategy, aligning with the Target Market of Intuitive Surgical.

Intuitive Surgical Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, Intuitive Surgical has seen consistent growth and strategic leadership changes. Institutional investors continue to be the primary owners, with their stake remaining robust. The company's financial performance has been strong, supported by increasing procedure volumes and system placements.

Recent developments at Intuitive Surgical highlight a period of significant expansion and leadership evolution. The company reported impressive financial results, with 2024 revenue reaching approximately $8.35 billion, marking a 17% increase from the previous year. This growth trajectory continued into Q2 2025, where revenue rose 21% year-over-year to $2.44 billion, largely propelled by a 17% surge in procedure volumes. The installed base of da Vinci systems expanded to 10,189 by March 31, 2025, with 367 systems placed in Q1 2025, indicating a 15% year-over-year growth in the installed base. The company also placed 1,430 da Vinci multiport systems throughout 2024. A key leadership transition was announced in May 2025, with Dave Rosa set to succeed Gary Guthart as CEO on July 1, 2025, after a 29-year tenure at the company. Gary Guthart will move to the role of executive chair of the board, while Craig Barratt will serve as lead independent director. Further executive promotions were made on January 3, 2025, including Henry Charlton as Executive Vice President and Chief Commercial and Marketing Officer, Gary Loeb as Executive Vice President and Chief Legal and Compliance Officer, and Jamie Samath as Executive Vice President, Chief Financial Officer and Enterprise Technology Leader. The company's financial health is robust, with a substantial cash and investments balance of $9.5 billion as of Q2 2025 and no outstanding debt, providing considerable financial flexibility. Intuitive Surgical continues its commitment to innovation, evidenced by the rollout of its da Vinci 5 system, which saw 362 systems placed in 2024, with over 2,500 surgeons utilizing the platform for more than 32,000 procedures during its initial commercialization phase. The company anticipates worldwide da Vinci procedures to grow between 13% and 16% in 2025. Furthermore, Intuitive Ventures, the company's venture capital arm, launched a second fund in December 2023 with $150 million in new capital, bringing its total assets under management to $250 million, to support early-stage companies in the minimally invasive care sector. This strategic investment aligns with the company's overall Growth Strategy of Intuitive Surgical.

Leadership Transition

Dave Rosa will become CEO on July 1, 2025, succeeding Gary Guthart. Guthart will transition to executive chair of the board.

Financial Performance

Revenue reached $8.35 billion in 2024, a 17% increase. Q2 2025 revenue was $2.44 billion, up 21% year-over-year.

Installed Base Growth

The da Vinci system installed base reached 10,189 by March 31, 2025. Q1 2025 saw 367 systems placed, a 15% increase year-over-year.

Innovation and Investment

The da Vinci 5 system is being rolled out, with 362 systems placed in 2024. Intuitive Ventures expanded its fund to $250 million.

Intuitive Surgical Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔